RecallDepth
Class III Ongoing

Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Madya Pradesh, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-323-90

This recall is currently active, issued June 18, 2025. It was issued by Glenmark Pharmaceuticals Inc., Usa.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
May 19, 2025
Posted
June 18, 2025
Recall Number
D-0462-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6,759 Con - 90 bottle pack
Firm Location
Mahwah, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.

Distribution

Nationwide USA and PR

Lot / Code Info

Lot #: 17240195, Exp 01/31/2026.

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class III Drug recalls